TY - JOUR AU - Messiou, C. AU - Kaiser, M. PY - 2018 DA - 2018// TI - Whole-body imaging in multiple myeloma JO - Magn Reson Imaging Clin N Am VL - 26 UR - https://doi.org/10.1016/j.mric.2018.06.006 DO - 10.1016/j.mric.2018.06.006 ID - Messiou2018 ER - TY - JOUR AU - Giles, S. L. PY - 2015 DA - 2015// TI - Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden JO - Clin Radiol VL - 70 UR - https://doi.org/10.1016/j.crad.2015.02.013 DO - 10.1016/j.crad.2015.02.013 ID - Giles2015 ER - TY - JOUR AU - Pawlyn, C. PY - 2016 DA - 2016// TI - Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? JO - Leukemia VL - 30 UR - https://doi.org/10.1038/leu.2015.338 DO - 10.1038/leu.2015.338 ID - Pawlyn2016 ER - TY - JOUR AU - Rasche, L. PY - 2017 DA - 2017// TI - Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma JO - Blood VL - 130 UR - https://doi.org/10.1182/blood-2017-03-774422 DO - 10.1182/blood-2017-03-774422 ID - Rasche2017 ER - TY - JOUR AU - Messiou, C. AU - Kaiser, M. PY - 2015 DA - 2015// TI - Whole body diffusion weighted MRI--a new view of myeloma JO - Br J Haematol VL - 171 UR - https://doi.org/10.1111/bjh.13509 DO - 10.1111/bjh.13509 ID - Messiou2015 ER - TY - JOUR AU - Dimopoulos, M. A. PY - 2015 DA - 2015// TI - Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.9961 DO - 10.1200/JCO.2014.57.9961 ID - Dimopoulos2015 ER - TY - JOUR AU - Hillengass, J. PY - 2010 DA - 2010// TI - Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.5356 DO - 10.1200/JCO.2009.25.5356 ID - Hillengass2010 ER - TY - JOUR AU - Merz, M. PY - 2014 DA - 2014// TI - Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2014.75 DO - 10.1038/leu.2014.75 ID - Merz2014 ER - TY - JOUR AU - Kastritis, E. PY - 2013 DA - 2013// TI - Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2012.309 DO - 10.1038/leu.2012.309 ID - Kastritis2013 ER - TY - JOUR AU - Mateos, M. V. PY - 2013 DA - 2013// TI - Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1300439 DO - 10.1056/NEJMoa1300439 ID - Mateos2013 ER - TY - JOUR AU - Moulopoulos, L. A. PY - 2005 DA - 2005// TI - Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma JO - Ann Oncol VL - 16 UR - https://doi.org/10.1093/annonc/mdi362 DO - 10.1093/annonc/mdi362 ID - Moulopoulos2005 ER - TY - JOUR AU - Mai, E. K. PY - 2015 DA - 2015// TI - A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma JO - Haematologica VL - 100 UR - https://doi.org/10.3324/haematol.2015.124115 DO - 10.3324/haematol.2015.124115 ID - Mai2015 ER - TY - JOUR AU - Hillengass, J. PY - 2019 DA - 2019// TI - International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders JO - Lancet Oncol VL - 20 UR - https://doi.org/10.1016/S1470-2045(19)30309-2 DO - 10.1016/S1470-2045(19)30309-2 ID - Hillengass2019 ER - TY - JOUR AU - Moreau, P. PY - 2017 DA - 2017// TI - Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx096 DO - 10.1093/annonc/mdx096 ID - Moreau2017 ER - TY - JOUR AU - Chantry, A. PY - 2017 DA - 2017// TI - Guidelines for the use of imaging in the management of patients with myeloma JO - Br J Haematol VL - 178 UR - https://doi.org/10.1111/bjh.14827 DO - 10.1111/bjh.14827 ID - Chantry2017 ER - TY - JOUR AU - Messiou, C. PY - 2012 DA - 2012// TI - Assessing response of myeloma bone disease with diffusion-weighted MRI JO - Br J Radiol VL - 85 UR - https://doi.org/10.1259/bjr/52759767 DO - 10.1259/bjr/52759767 ID - Messiou2012 ER - TY - JOUR AU - Giles, S. L. PY - 2014 DA - 2014// TI - Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma JO - Radiology VL - 271 UR - https://doi.org/10.1148/radiol.13131529 DO - 10.1148/radiol.13131529 ID - Giles2014 ER - TY - JOUR AU - Messiou, C. PY - 2019 DA - 2019// TI - Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS) JO - Radiology VL - 291 UR - https://doi.org/10.1148/radiol.2019181949 DO - 10.1148/radiol.2019181949 ID - Messiou2019 ER - TY - JOUR AU - Rajkumar, S. V. PY - 2016 DA - 2016// TI - Updated diagnostic criteria and staging system for multiple myeloma JO - Am Soc Clin Oncol Educ Book VL - 35 UR - https://doi.org/10.14694/EDBK_159009 DO - 10.14694/EDBK_159009 ID - Rajkumar2016 ER - TY - JOUR AU - Koo, T. K. AU - Li, M. Y. PY - 2016 DA - 2016// TI - A guideline of selecting and reporting Intraclass correlation coefficients for reliability research JO - J Chiropr Med VL - 15 UR - https://doi.org/10.1016/j.jcm.2016.02.012 DO - 10.1016/j.jcm.2016.02.012 ID - Koo2016 ER -